10 Followers on Owler

F2G

is an England-based clinical-stage biopharmaceutical company that discovers and develops novel therapies for the treatment of rare fungal diseases... Read more
OverviewCompetitorsFundingNews & Insights

F2G

is an England-based clinical-stage biopharmaceutical company that discovers and develops novel therapies for the treatment of rare fungal diseases... Read more
F2G CEO: Francesco Maria Lavino

CEO

Francesco Maria Lavino

CEO Approval Rating

90/100

1998

Private

Pharmaceuticals & Biotechnology
PharmaceuticalsBiotechnology
2834 NAICS listing

Est. Annual Revenue
$100-500M
Agree?
Est. Employees
25-100
Agree?
Funding
$369.6M

News

Funding
Sep 12, 2024
GlobalNewswire
F2G received $100M in Equity Funding

F2G Competitors

1Cidara
2Amplyx
3SCYNEXIS
4Entasis
5Basilea
6Viamet Pharma
7Astellas
8Gossamer Bio
9NGM Bio
10AiCuris
Unlock 16 + competitors

Trending Companies